Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 4,866 | 6,933 | 6,165 | 3,261 | 10,813 |
| Cost of Goods | 1,558 | 1,418 | 2,590 | 2,130 | 3,055 |
| Gross Profit | 3,308 | 5,515 | 3,575 | 1,131 | 7,758 |
| Operating Expenses | 32,764 | 38,273 | 31,815 | 32,568 | 31,658 |
| Operating Income | -28,898 | -32,340 | -27,650 | -31,307 | -23,845 |
| Other Income | 866 | 861 | 985 | 968 | 665 |
| Pre-tax Income | -28,032 | -31,479 | -26,665 | -30,339 | -23,180 |
| Net Income Continuous | -28,032 | -31,479 | -26,665 | -30,339 | -23,180 |
| Net Income | $-28,032 | $-31,479 | $-26,665 | $-30,339 | $-23,180 |
| EPS Basic Total Ops | -18.73 | -20.89 | -17.65 | -20.27 | -15.49 |
| EPS Basic Continuous Ops | -18.62 | -21.00 | -17.83 | -20.31 | -15.54 |
| EPS Diluted Total Ops | -18.73 | -20.89 | -17.65 | -20.27 | -15.49 |
| EPS Diluted Continuous Ops | -18.62 | -21.00 | -17.83 | -20.31 | -15.54 |
| EBITDA(a) | $-28,480 | $-31,858 | $-27,311 | $-31,113 | $-23,456 |